Senior Director, Corporate Affairs Lead - V&I jobs in United States
cer-icon
Apply on Employer Site
company-logo

AstraZeneca · 3 hours ago

Senior Director, Corporate Affairs Lead - V&I

AstraZeneca is dedicated to developing vaccines and antibody therapies to combat global health challenges. The Senior Director, Corporate Affairs Lead for V&I will oversee the Global Corporate Affairs function, leading strategic corporate affairs initiatives and collaborating with various stakeholders to enhance access to medicines and vaccines.

BiopharmaBiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
check
Comp. & Benefits

Responsibilities

Leads the Global Corporate Affairs function for V&I, accountable for strategic corporate affairs strategies, plans, SMART goals/clear metrics; works across policy, advocacy and international/external communications from R&D through commercialisation. Leads prioritisation and provides guidance to GCA colleagues and team members
Lead policy and advocacy strategies and programmes to drive healthcare policy / system reforms and transform healthcare systems to support access to medicines/vaccines, transform healthcare systems to deliver better standards of care and ultimately market class growth for our disease areas. Includes leading relationships with patient advocacy groups
Lead evidence generation, including peer review studies and argumentation to support policymaker decision-making, working in collaboration with external experts and cross functional (corporate affairs, medical, market access, commercial, global/country) teams
Effectively represents AstraZeneca and supports leaders representing AstraZeneca with relevant third-party groups/trade bodies on topics relevant to the V&I portfolio
Builds AstraZeneca’s reputation in V&I with priority stakeholder groups including the portfolio/pipeline, key disease areas, scientific platforms and other leadership platforms. Includes working at global stakeholder level and supporting priority regions/countries. Includes leveraging priority platforms/events eg medical congresses
Ensure management of potential and/or active issues with the potential to impact AZ reputation and/or business by providing counsel to leaders, managing internal/external stakeholders and delivers relevant communications
Partners with leaders to translate the V&I strategy into internal and external communications

Qualification

Pharmaceutical industry experienceAccess to medicinesDisease-level policy reformPatient advocacy relationsStrategic capabilityLine management experienceInfluencing skillsEntrepreneurial attitudeCollaboration skills

Required

Graduate (Bachelor's/Master's) with 10-15 years' experience in the pharmaceutical industry or large-scale NGO/public health body
Proven track-record in access to medicines, disease-level policy reform and impactful patient advocacy relations including multi-stakeholder campaigning
Strong strategic capability
Proven ability to serve as an engaged, credible advisor to senior executives and leaders with strong ability to translate strategy into effective communications
Self-starting, independent, entrepreneurial attitude – a smart risk-taker who thrives on new challenges and on seeing things through to completion with impact
Eagerness and ability to collaborate with and mobilize different people and organizations; work effectively in a matrix organization and ability to prioritise effectively
Line management experience (role does not have direct reports but oversees deployed team members)
Ability to collaborate with and influence teams across functions and geographical boundaries

Benefits

Qualified retirement programs
Paid time off (i.e., vacation, holiday, and leaves)
Health, dental, and vision coverage in accordance with the terms of the applicable plans

Company

AstraZeneca

company-logo
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.

Funding

Current Stage
Public Company
Total Funding
$5.26B
2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B

Leadership Team

leader-logo
Pascal Soriot
Chief Executive Officer
leader-logo
Aradhana Sarin
Group CFO and Executive Director
linkedin
Company data provided by crunchbase